Company Quick10K Filing
Bravatek Solutions
10-Q 2019-09-30 Filed 2019-11-15
10-Q 2019-06-30 Filed 2019-07-24
10-Q 2019-03-31 Filed 2019-06-25
10-K 2018-12-31 Filed 2019-06-11
S-1 2018-10-26 Public Filing
10-Q 2018-09-30 Filed 2018-12-04
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-18
10-Q 2017-09-30 Filed 2017-10-30
10-Q 2017-06-30 Filed 2017-10-06
10-K 2017-03-31 Filed 2017-09-27
10-Q 2016-12-31 Filed 2017-08-29
10-Q 2016-09-30 Filed 2017-08-23
10-Q 2016-06-30 Filed 2017-08-10
10-K 2016-03-31 Filed 2017-07-21
10-Q 2015-12-31 Filed 2016-02-22
10-Q 2015-09-30 Filed 2015-11-20
10-Q 2015-06-30 Filed 2015-08-24
10-K 2015-03-31 Filed 2015-08-05
10-Q 2014-12-31 Filed 2015-02-25
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-20
10-K 2014-03-31 Filed 2014-07-14
10-Q 2013-12-31 Filed 2014-02-18
10-Q 2013-09-30 Filed 2013-11-18
10-Q 2013-06-30 Filed 2013-08-15
10-K 2013-03-31 Filed 2013-07-15
10-Q 2012-12-31 Filed 2013-02-19
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-20
10-K 2012-03-31 Filed 2012-06-11
10-Q 2011-12-31 Filed 2012-02-21
10-Q 2011-09-30 Filed 2011-11-18
10-Q 2011-06-30 Filed 2011-08-15
10-K 2011-03-31 Filed 2011-07-01
10-Q 2010-12-31 Filed 2011-02-16
10-Q 2010-09-30 Filed 2010-11-19
10-Q 2010-06-30 Filed 2010-08-16
10-K 2010-03-31 Filed 2010-07-13
10-Q 2009-12-31 Filed 2010-02-16
8-K 2020-03-30
8-K 2019-10-31
8-K 2019-03-13
8-K 2019-03-02
8-K 2019-02-18
8-K 2019-01-25
8-K 2018-11-13
8-K 2018-08-31
8-K 2018-07-27
8-K 2018-06-01
8-K 2018-05-08
8-K 2018-03-28
8-K 2018-03-14
8-K 2018-02-15
8-K 2018-02-03
8-K 2018-01-25
8-K 2018-01-12
8-K 2018-01-10
8-K 2018-01-05
8-K 2018-01-05

Bravatek Solutions Financials

BVTK Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3012735742111569316292620317331531006621276639140632
Accounts Receivable25029647191600653622992612800112
Inventory352
PP&E2321196912121110987664441383633312926243383383991101101106
Assets533392725823267811233632366379451148988153462914454,2264,0984,1511257099151
Accounts Payable
Long-Term Debt10034940831531932633411511701,8783,0911,3861,417163156115
Liabilities5335927529361,0351,1371,3181,5121,5391,6471,7741,8562,5023,6175,0634,5104,9535,8515,5225,1747,90614,4579,4488,7218,1198,7977,1907,8238,437
Stockholders' Equity-480-559-660-864-978-1,114-1,292-1,434-1,527-1,623-1,738-1,824-2,136-3,237-4,613-4,363-4,854-5,770-5,469-5,128-7,615-14,013-5,222-4,623-3,966-8,673-7,120-7,724-8,285
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue011100100063120-18345107510751,0691,768662860113
Cost of Revenue6526891288541028211,44647402034
Gross Profit-294-683320-4-107324832118886-2079
R&D17253321926221101615000
SG&A67115274150791521299740432015214229912829276113128181326116215149180
Tax000000000000
Net Income-88-141-304-167-114-187-183-149-97-6,355-265-164-917-1,645-2,886-620-82131262-8,445-9,1434657,053-5541,233-604-867
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-63-77-116-79-101-127-66-67-71-61-455-259-52-26-298-263-345-375-3-14-191-61
Cash Investing00-162-10000-30-12700-200-38-2610000
Cash Financing451381005010618008085585013684025563409269388-61-02540